NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss Post published:November 19, 2020 Post category:Press Release
Nova Mentis Life Science Announces Receipt of Pilz Shareholder Approval Post published:November 18, 2020 Post category:Press Release
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders Post published:November 18, 2020 Post category:Press Release
PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform Post published:November 18, 2020 Post category:Press Release
Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics Post published:November 18, 2020 Post category:Press Release
Novamind and Hinterland Metals Enter into Amalgamation Agreement Post published:November 17, 2020 Post category:Press Release
First Non-Palliative Canadian Granted Access To Psilocybin Therapy Post published:November 17, 2020 Post category:News
Red Light Holland Engages RadixMotion to Develop iMicrodose Digital Care Program Using Latest Immersive Technology Post published:November 17, 2020 Post category:Press Release
Mydecine Innovations Group Offers Management and Clinical Trials Update Post published:November 17, 2020 Post category:Press Release
Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program Post published:November 17, 2020 Post category:Press Release